
Enliven Therapeutics, Inc.
NASDAQ:ELVN
22.29 (USD) • At close June 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||||||
Current Assets: | ||||||||||||||||||||||
Cash & Cash Equivalents
| 101.705 | 124.117 | 100.621 | 96.871 | 149.219 | 100.195 | 73.847 | 125.715 | 292.102 | 88.198 | 86.159 | 30.433 | 36.484 | 110.024 | 75.295 | 48.037 | 53.441 | 47.698 | 34.158 | 54.651 | 86.722 | 4.936 |
Short Term Investments
| 187.85 | 189.323 | 191.213 | 215.519 | 171.339 | 153.007 | 189.631 | 152.15 | 0 | 0 | 6.813 | 29.907 | 36.416 | 41.969 | 27.544 | 18.731 | 22.151 | 40.524 | 61.931 | 51.624 | 19.145 | 23.971 |
Cash and Short Term Investments
| 289.555 | 313.44 | 291.834 | 312.39 | 320.558 | 253.202 | 263.478 | 277.865 | 292.102 | 88.198 | 86.159 | 60.34 | 72.9 | 110.024 | 102.839 | 66.768 | 75.592 | 88.222 | 96.089 | 106.275 | 105.867 | 28.907 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 4.763 | 4.687 | 5.163 | 5.737 | 16.695 | 13.003 | 5.128 | 5.31 | 5.901 | 3.655 | 2.07 | 3.916 | 5.628 | 0.646 | 3.158 | 4.589 | 4.769 | 2.183 | 3.622 | 4.318 | 3.949 | 1.717 |
Total Current Assets
| 294.318 | 318.127 | 296.997 | 318.127 | 337.199 | 266.151 | 268.606 | 283.175 | 298.003 | 89.636 | 88.229 | 64.256 | 78.528 | 110.67 | 105.997 | 71.357 | 80.361 | 90.405 | 99.711 | 110.593 | 109.816 | 30.624 |
Non-Current Assets: | ||||||||||||||||||||||
Property, Plant & Equipment, Net
| 1.055 | 0.458 | 0.63 | 0.791 | 0.924 | 1.062 | 1.204 | 1.342 | 1.404 | 1.516 | 1.553 | 0.235 | 2.899 | 0.954 | 0.855 | 0.936 | 1.018 | 0.349 | 0.376 | 0.4 | 0.418 | 0.442 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0.054 | 0.054 | 0.054 | 0 | 0 | 0.175 | 0.175 | 41.969 | 0.175 | 0.175 | 0.088 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 7.197 | 7.175 | 7.803 | 8.125 | 4.654 | 4.654 | 4.177 | 3.93 | 3.405 | 0.807 | 1.013 | 0 | 0 | -40.264 | 0 | 0 | 0.22 | 0.088 | 0.088 | 0.324 | 0.088 | 2.232 |
Total Non-Current Assets
| 8.252 | 7.633 | 8.433 | 8.916 | 5.578 | 5.716 | 5.435 | 5.326 | 4.863 | 2.323 | 2.566 | 0.41 | 3.074 | 2.659 | 1.03 | 1.111 | 1.326 | 0.437 | 0.464 | 0.724 | 0.506 | 2.674 |
Total Assets
| 302.57 | 325.76 | 305.43 | 327.043 | 342.777 | 271.867 | 274.041 | 288.501 | 302.866 | 91.959 | 90.795 | 64.666 | 81.602 | 113.329 | 107.027 | 72.468 | 81.687 | 90.842 | 100.175 | 111.317 | 110.322 | 33.298 |
Liabilities & Equity: | ||||||||||||||||||||||
Current Liabilities: | ||||||||||||||||||||||
Account Payables
| 1.562 | 1.342 | 1.019 | 1.083 | 2.727 | 0.532 | 1.493 | 2.843 | 5.86 | 3.438 | 2.993 | 1.135 | 1.884 | 2.521 | 2.476 | 2.626 | 3.001 | 1.971 | 1.886 | 1.669 | 2.322 | 1.658 |
Short Term Debt
| 0 | 0 | 0.085 | 0.169 | 0.252 | 0.335 | 0.332 | 0.329 | 0.326 | 0.323 | 0.32 | 0.445 | 0.508 | 0.159 | 0.25 | 0.254 | 0.257 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0.232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 9.886 | 5.632 | 0 | -0.323 | 0 | 0 | 0 | 2.703 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 10.848 | 14.573 | 15.923 | 18.542 | 22.052 | 25.027 | 10.254 | 5.975 | 4.756 | 5.954 | 5.02 | 1.722 | 4.831 | 3.073 | 4.462 | 4.093 | 2.245 | 4.276 | 3.424 | 3.179 | 2.627 | 2.54 |
Total Current Liabilities
| 13.972 | 15.915 | 17.027 | 22.105 | 25.031 | 25.894 | 12.079 | 9.147 | 10.942 | 1.83 | 8.333 | 3.302 | 7.223 | 5.753 | 7.188 | 6.973 | 5.503 | 6.247 | 5.31 | 4.848 | 4.949 | 4.198 |
Non-Current Liabilities: | ||||||||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.967 | 0 | 0.932 | 1.056 | 1.18 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.173 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.302 | 0 | 0 | 0.006 | 0.034 | 0.067 | 0.214 | 0.36 | 0.508 | 150.408 | 150.559 | 1.58 | 0 | 150.463 | -0.466 | -0.528 | -0.59 | 0.16 | 0.167 | 0 | 0.179 | 0.184 |
Total Non-Current Liabilities
| 0.302 | 0 | 0 | 0.006 | 0.034 | 0.067 | 0.214 | 0.36 | 0.508 | 150.408 | 150.559 | 1.58 | 1.967 | 150.463 | 0.466 | 0.528 | 0.59 | 0.16 | 0.167 | 0.173 | 0.179 | 0.184 |
Total Liabilities
| 14.274 | 15.915 | 17.027 | 22.111 | 25.065 | 25.961 | 12.293 | 9.507 | 11.45 | 1.83 | 158.892 | 3.302 | 9.19 | 156.216 | 7.654 | 7.501 | 6.093 | 6.407 | 5.477 | 5.021 | 5.128 | 4.382 |
Equity: | ||||||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 271.867 | 0 | 0 | 0 | 0.15 | 0.15 | 0 | 149.749 | 149.749 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.049 | 0.049 | 0.047 | 0.047 | 0.047 | 0.041 | 0.041 | 0.041 | 0.041 | 0.027 | 0.001 | 0.027 | 0.027 | 0.001 | 0.027 | 0.019 | 0.018 | 0.018 | 0.018 | 0.018 | 0.017 | 0.01 |
Retained Earnings
| -272.016 | -243.472 | -220.292 | -197.136 | -177.186 | -154.448 | -135.078 | -114.309 | -97.588 | -146.009 | -73.314 | -173.585 | -162.136 | -45.202 | -133.178 | -119.531 | -106.37 | -96.113 | -84.595 | -72.172 | -61.968 | -54.753 |
Accumulated Other Comprehensive Income/Loss
| -0.016 | 0.055 | 0.242 | -0.139 | -0.053 | 0.141 | -0.147 | -0.111 | -0 | -0.177 | -0.004 | -0.035 | -0.051 | -0.016 | -0.002 | 0 | 0.001 | 0.004 | 0.024 | 0.048 | -0.016 | 0.032 |
Other Total Stockholders Equity
| 560.279 | 553.213 | 508.406 | 502.16 | 494.904 | 400.172 | 396.932 | 393.373 | 388.963 | 236.111 | 5.22 | 234.957 | 84.823 | 2.33 | 232.526 | 184.479 | 181.945 | 180.526 | 179.251 | 178.402 | 167.161 | 83.627 |
Total Shareholders Equity
| 288.296 | 309.845 | 288.403 | 304.932 | 317.712 | 245.906 | 261.748 | 278.994 | 291.416 | 90.129 | -68.097 | 61.364 | 72.412 | -42.887 | 99.373 | 64.967 | 75.594 | 84.435 | 94.698 | 106.296 | 105.194 | 28.916 |
Total Equity
| 0 | 309.845 | 288.403 | 304.932 | 317.712 | 245.906 | 261.748 | 278.994 | 291.416 | 90.129 | -68.097 | 61.364 | 72.412 | -42.887 | 99.373 | 64.967 | 75.594 | 84.435 | 94.698 | 106.296 | 105.194 | 28.916 |
Total Liabilities & Shareholders Equity
| 302.57 | 325.76 | 305.43 | 327.043 | 342.777 | 271.867 | 274.041 | 288.501 | 302.866 | 91.959 | 90.795 | 64.666 | 81.602 | 113.329 | 107.027 | 72.468 | 81.687 | 90.842 | 100.175 | 111.317 | 110.322 | 33.298 |